1.82
-0.04 (-2.15%)
-0.04 (-2.15%)
Upgrade to Real-Time
Afterhours
| Volume | 1,052,385 |
|
|||||
| News | - | ||||||
| Day High | 1.90 | Low High |
|||||
| Day Low | 1.73 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Alaunos Therapeutics Inc | TCRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.04 | -2.15% | 1.82 | 17:00:47 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.85 | 1.73 | 1.90 | 1.78 | 1.86 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,349 | 1,052,385 | $ 1.82 | $ 1,916,989 | - | 0.4053 - 1.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:00:47 | formt | 399 | $ 1.82 | USD |
Period:
Draw Mode:
Alaunos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 393.03M | 215.95M | 184.60M | $ 398.00k | $ - | -0.38 | -5.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1.70M | 4.70% |
Alaunos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TCRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.58 | 1.90 | 1.52 | 1.74 | 1,837,018 | 0.24 | 15.19% |
| 1 Month | 1.45 | 1.90 | 1.00 | 1.43 | 1,500,531 | 0.37 | 25.52% |
| 3 Months | 0.4873 | 1.90 | 0.45 | 0.9536626 | 3,092,441 | 1.33 | 273.49% |
| 6 Months | 0.92 | 1.90 | 0.4053 | 0.8167695 | 2,685,737 | 0.90 | 97.83% |
| 1 Year | 0.866 | 1.90 | 0.4053 | 0.8239865 | 2,662,486 | 0.954 | 110.16% |
| 3 Years | 0.866 | 1.90 | 0.4053 | 0.8239865 | 2,662,486 | 0.954 | 110.16% |
| 5 Years | 0.866 | 1.90 | 0.4053 | 0.8239865 | 2,662,486 | 0.954 | 110.16% |
Alaunos Therapeutics Description
| Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations. |